Related references
Note: Only part of the references are listed.Mammalian Target of Rapamycin: Its Role in Early Neural Development and in Adult and Aged Brain Function
Carla Garza-Lombo et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2016)
Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis
Eleonora Patsenker et al.
JOURNAL OF HEPATOLOGY (2011)
The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
Michelle C. Mendoza et al.
TRENDS IN BIOCHEMICAL SCIENCES (2011)
Relevance of the mTOR signaling pathway in the pathophysiology of splenomegaly in rats with chronic portal hypertension
Marc Mejias et al.
JOURNAL OF HEPATOLOGY (2010)
Rapamycin Inhibits Hepatic Fibrosis in Rats by Attenuating Multiple Profibrogenic Pathways
Kim R. Bridle et al.
LIVER TRANSPLANTATION (2009)
Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
Morris E. Feldman et al.
PLOS BIOLOGY (2009)
Rapamycin prevents mesenteric neo-angiogenesis and reduces splanchnic blood flow in portal hypertensive mice
Anja M. Geerts et al.
HEPATOLOGY RESEARCH (2008)
Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation
Andrew Y. Choo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Phosphatidylinositol 3-kinase/Akt pathway regulates hepatic stellate cell apoptosis
Yan Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
All roads lead to mTOR - Integrating inflammation and tumor angiogenesis
Dung-Fang Lee et al.
CELL CYCLE (2007)
Antiangiogenic treatment with Sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats
Snia Tugues et al.
HEPATOLOGY (2007)
Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats
Mercedes Fernandez et al.
HEPATOLOGY (2007)
Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis
Markus Neef et al.
JOURNAL OF HEPATOLOGY (2006)
S6K1 regulates GSK3 under conditions of mTOR-dependent feedback inhibition of Akt
Hui H. Zhang et al.
MOLECULAR CELL (2006)
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB
DD Sarbassov et al.
MOLECULAR CELL (2006)
Complexity of the TOR signaling network
K Inoki et al.
TRENDS IN CELL BIOLOGY (2006)
mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt
KE O'Reilly et al.
CANCER RESEARCH (2006)
Phosphorylation and functional inactivation of TSC2 by Erk: Implications for tuberous sclerosis and cancer pathogenesis
Li Ma et al.
CELL (2006)
Growing roles for the mTOR pathway
DD Sarbassov et al.
CURRENT OPINION IN CELL BIOLOGY (2005)
Long-term treatment of bile duct-ligated rats with rapamycin (sirolimus) significantly attenuates liver fibrosis:: Analysis of the underlying mechanisms
E Biecker et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Phosphorylation and functional inactivation of TSC2 by Erk: Implications for tuberous sclerosis and cancer pathogenesis
L Ma et al.
CELL (2005)
The role of p70S6K in hepatic stellate cell collagen gene expression and cell proliferation
E Gäbele et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Bile acids induce hepatic stellate cell proliferation via activation of the epidermal growth factor receptor
G Svegliati-Baroni et al.
GASTROENTEROLOGY (2005)
Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease
YX Tao et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Implication of inflammation-related cytokines in the natural history of liver cirrhosis
JA Girón-González et al.
LIVER INTERNATIONAL (2004)
Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways
MH Schoemaker et al.
HEPATOLOGY (2004)
Mammalian target of rapamycin positively regulates collagen type I production via a phosphatidylinositol 3-kinase-independent pathway
D Shegogue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Regulation of ERK/JNK/p70S6K in two rat models of liver injury and fibrosis
G Svegliati-Baroni et al.
JOURNAL OF HEPATOLOGY (2003)
Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct-ligated mice
JS Gujral et al.
HEPATOLOGY (2003)
The role of focal adhesion kinase-phosphatidylinositol 3-kinase-Akt signaling in hepatic stellate cell proliferation and type I collagen expression
S Reif et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Liver fibrosis: Signals leading to the amplification of the fibrogenic hepatic stellate cell
E Gabele et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2003)
PI3K-FRAP/mTOR pathway is critical for hepatocyte proliferation whereas MEK/ERK supports both proliferation and survival
A Coutant et al.
HEPATOLOGY (2002)
Intracellular pathways mediating estrogen-induced cholangiocyte proliferation in the rat
D Alvaro et al.
HEPATOLOGY (2002)
Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes
L Qiao et al.
HEPATOLOGY (2002)
Activation of the Raf-1/MEK/ERK cascade by bile acids occurs via the epidermal growth factor receptor in primary rat hepatocytes
YP Rao et al.
HEPATOLOGY (2002)
Transient expression of IL-1β induces acute lung injury and chronic repair leading to pulmonary fibrosis
M Kolb et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
TOR, a central controller of cell growth
T Schmelzle et al.
CELL (2000)
Share Paper
